in the august 2009 issue of Nature Reviews Cardiology, errors were published in table 2 (page 529) of the review article by louai razzouk and Michael e. Farkouh. For the hats trial, the end point(s) should read "change in stenosis measured by arteriography"; the results should read "stenosis regressed by 0.4% with simvastatin plus niacin compared with a 3.9% increase with placebo over 2 years (P <0.001)". For the arBiter-2 trial, the results should read "Mean ciMt increased significantly from baseline with placebo added to simvastatin (0.044 ± 0.100 mm; P <0.001) and was unchanged with niacin added to simvastatin (0.014 ± 0.104 mm; P = 0.23) over 1 year". For the arBiter-3 trial, the results should read "ciMt regressed by -0.027 ± 0.011 mm with niacin added to simvastatin over 1 year (P <0.001 compared with placebo added to simvastatin); patients treated for 2 years showed further regression of ciMt of 0.041 ± 0.021 mm (P = 0.001 compared with placebo added to simvastatin)".
